DELAYED RECOVERY OF MYOCARDIAL BLOOD FLOW AFTER CARDIAC STEM CELL ADMINISTRATION LIMITS CELL HOMING
Mariann Gyöngyösi(Medical University of Vienna), Gerald Maurer(European Society of Radiology), Silvia Charwat(Medical University of Vienna), Renate Hofer-Warbinek(Medical University of Vienna), Anikó Pósa(University of Szeged), Флориан Грубер(Christian Doppler Laboratory for Thermoelectricity), Susanne Wolbank(Austrian Cluster for Tissue Regeneration), Rainer de Martin(Deaconess Hospital), Christoph Kaun(University of Vienna), Örs Petneházy(Domus Medica), Zsolt Petrási(University of Kaposvár), Rayyan Hemetsberger(Medical University of Vienna)
Cited by 0
Related Papers
Vitamin C Enhances the Generation of Mouse and Human Induced Pluripotent Stem Cells
|Cell stem cell|2010|971
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
|Nature Biotechnology|2010|406
Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial Cells
|Circulation Research|2019|312
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension
|Thrombosis and Haemostasis|2005|296